Bone tumors • 200 benign types • 90 malignant conditions • Relative incidence benign/ malign 200 :1 • USA (2004) – annual incidence : 8600 2400 new cases • Cancer mortality – 563000 cases/year - sarcomas are just a small fraction
Etiology of musculuo-skeletal tumors Tumorigenesis -complex multiple-step process by which healthy tissue progressively from a normal phenotype into an abnormal colony of proliferating cells. -Cells aquire genetic abnormalities in oncogenesis, tumor supresor genes and other genes that directly or indirectly control proliferation -Such a process may progress beyond the controlled state of benigned deasease to became a dedifferetiated, aggressive and immortal phenotype by genomic instability -The instability allows the cell to progress tu fulminant malignancy
Evaluation and staging of tumors • History and physical examination Questions to ask : 1. The patients age 2. Duration of complaint 3. Rate of growth 4. Pain associated with the tumor 5. History of trauma 6.Personal or family history of cancer 7. Sistemic signs or simptoms
Distribution of bone tumors by age
NEUROBLA
Aspects of the physical examination • • • • • • • • • •
Skin colour Warmth Location Swelling Neurovascular exam. Joint range of motion Size Tenderness Firmness Lymph nodes
1 G0T0M0
IA
G1T1M0
2 G0T1M0
IB
G1T2M0
3 G0T1M0-1
II A
G2T1M0
II B
G2T2M0
III A
G1-2 T1M1
III B
G1-2 T2M1
CLINICAL SIGNS
• pain • diformity • fracture on pathological bone
Imaging studies CONVENTIONAL RADIOGRAPHY • lesion extensions • lesion aggressivity • bone distruction (OSTEOLYSIS) • bone formation (OSTEOCONDENSATION) • periosteal osteogenesis (periosteal reaction)
RADIOGRAPHY Periosteal reaction
LAB EXPLORATION Lung X-Ray
LAB EXPLORATION Computerised Tomography (CT) Defines the tumor extension in the extraosseous soft tissues
LAB EXPLORATION Magnetic Resonance Imager (MRI) Defines tumor extension
LAB EXPLORATION Scintigraphy Technetium99 Hyperfixation Early signs Tumor extension Tumor evolution Metastasis
LAB EXPLORATION Angiography Normal
Femur osteosarcoma
LAB EXPLORATION Biopsy SURGICAL
Trained team Atraumatic technique Between two tourniquets Using the electrocautery
Roentgen guided TRANSCUTANEOUS
Useful in metastasis
Histologic classification
TYPE BONE
SURGICAL CLASSIFICATION G tumor degree G0 benign histologic tumor G1 low malignancy tumor G2 high malignancy tumor
Enneking (1980)
T tumor topography T0 intracapsular and/or intracompartmenal tumour T1 extracapsular BUT intracompartmenal tumour T2 extracompartmental tumour M Metastasis M0 lack of metastasis M presence of metastasis
TUMOR TREATMENT Principles Treatment starts ONLY AFTER tumor histologic classification Treatment is realized by a TEAM formed by • radiologist • anatomopathologist • oncologist • surgeon
TUMOR TREATMENT Surgical principles EXCISION
TOTAL
AMPUTATION
TOTAL
EXTENDED EXTENDED
INTRALESIONAL MARGINAL (LIMITED)
TUMOR TREATMENT Filling bone defect
Plaster Graft Cement Osteosynthesis Reconstruction
TUMOR TREATMENT Filling articular defect
Pseudarthrosis Arthrodesis Arthroplasty
TUMOR TREATMENT Radiotherapy Curative action
Ewing sarcoma (child) Plasmocytoma (adult)
Symptomatic action (antalgic)
Scatter metastasis
Indications Stage 3 benign tumors Stage I malignant tumors Stage II malignant tumors
High penetrability/ Reduced treatment duration
TUMOR TREATMENT Chemiotherapy Cytotoxicity at DNA level Intraarterial selective administration Drug mixture Indications Stage 3 benign tumors Stage I malignant tumors Stage II malignant tumors (preoperatively)
Treatment result evaluation (histologic) I = necrotic cells < 50% II = necrotic cells 50-90% III = necrotic cells > 90% IV = necrotic cells 100%
TUMOR TREATMENT Extracorporeal irradiation
Pathological bone fracture - Osteosarcoma of humerus -
Osteosarcoma of humerus
Osteosarcoma of humerus
Ulcerated maligant tumor
Management of carcinoma metastasized to bone
SPITALUL CLINIC DE URGENŢE IAŞI
SPITALUL CLINIC DE URGENŢE IAŞI
Management of carcinoma metastasized to bone
day after tomorrow.wmv